跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sidapvia - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sidapvia
Approved
STANDARD
Sidapvia
SK Chemicals Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
776d00705180b6bd
Company
SK Chemicals Co., Ltd.
Type
Standard
Approval Details
Approval Id
776d00705180b6bd
Drug Approval Philippines Name
Sidapvia
Product Name
Sidapvia
Registration Number
DR-XY49396
Brand Name
Sidapvia
Generic Name
Dapagliflozin (as propanediol monohydrate) + Sitagliptin (as phosphate monohydrate)
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg/100 mg
Manufacturer
SK Chemicals Co., Ltd.
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Distributor
AstraZeneca Pharmaceuticals (Phils.), Inc.
Company Detail Path
/organization/sk-chemicals-co-ltd
Issuance Date
15 May 2025
Expiry Date
15 May 2030
Pharmacologic Category
Combinations of Oral Blood Glucose Lowering Drugs [Sodium-glucose co-transporter 2 (SGLT2) + Dipeptidyl peptidase 4 (DPP-4) inhibitor]
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
776d00705180b6bd
Type
Standard
Back to Philippines FDA Approvals